Cancer52 seeking a Strategy Consultant
Cancer52 will soon develop a new organisational strategy to guide our activities and goals from 2026 to 2029. We are looking for an...
Mar 13
Big Cancer52 Conversation, March 2025
Cancer52 held the Big Cancer52 Conversation on 26th March in Manchester.
Mar 13
Improving Diagnosis Report
Cancer52 is proud to launch their report ‘Improving diagnosis: Patient and clinician perspectives on increasing early diagnosis in rare and
Mar 5
Cancer52 Annual Review 2023-2024
Cancer52 is pleased to submit their Annual Review for the financial year 2023-2024 to the Charity Commission.
Feb 13
State of the Nation Report on Rare and Less Common Cancers
Released online for World Cancer Day on 4th February 2025, Cancer52 shared the 'State of the Nation report on Rare and Less Common Cancers.
Feb 4
Genomics England hosts Cancer52 Roundtable
Genomics England recently hosted a roundtable event with many Cancer52 members including: Sarcoma UK, Young Lives vs Cancer, Myeloma UK,...
Nov 8, 2024
Cancer52 Health Inequalities Report
Cancer52 has released its latest report on health inequalities , as part of the Big Cancer52 Conversation event. >> Read report...
Nov 7, 2024
Fair Market Value (FMV) Guidance
Fair Market Value (FMV) Guidance is now available to bring consistency to reimbursement for cross-sector partnership work. See FMV...
Nov 7, 2024
Cancer52 prepares briefing for debate on a future cancer strategy for England
Cancer52 has prepared a briefing for a Westminster Hall Debate  on the ‘Potential merits of a cancer strategy for England’ . The debate...
Oct 30, 2024
New member: The Sophie Fitzpatrick Charitable Foundation for Rare Cancers
We are delighted to welcome a new member! The Sophie Fitzpatrick Charitable Foundation for Rare Cancers.
Oct 14, 2024